#Project - “Skin and Radiotherapy” MEL13 RX

Scientific Communication for a Dermocosmetic Brand, by Joana Preto, Founder of A Pele Comunica®.

Context

Biolotus needed scientific and communication content for MEL13 RX, a dermocosmetic solution designed to support the management of radiodermatitis, one of the most common cutaneous adverse effects associated with radiotherapy. The brand required a partner able to translate complex clinical and scientific information into communication that would remain accurate for healthcare professionals, while staying clear and accessible for other relevant audiences.

Our contribution

• Scientific content analysis and review of clinical evidence related to radiodermitis management;

• Product positioning and key message development, aligned with Biolotus' scientific rationale;

• Creation of communication materials designed to strengthen understanding of the product's characteristics and clinical relevance.

Outcome

A scientific presentation built for multiple professional settings, from medical visits to public meetings and scientific conferences, ensuring scientific accuracy while maintaining a clear, engaging and coherent narrative aligned with Biolotus' positioning.

Have a project in mind?